About BBM
Technology & Platform
Media Center
Investor Relations
Careers
Contact Us
CN
搜索
菜单
About BBM
Technology & Platform
Media Center
Investor Relations
Careers
Contact US
Media Center
Press Releases
Media Reports
Official Statement
19
2026y08m
Expanded Access Policy for BBM-D101
Belief BioMed is an innovative biopharmaceutical company focused on the development of gene therapies. BBM-D101 is a recombinant adeno-associated virus (rAAV) gene therapy product independently developed by Belief BioMed with proprietary intellectual prop
Belief BioMed Investor Relations
Email: IR_BBM@beliefbiomed.com